Susceptibility to Killer T Cells of Gastric Cancer Cells Enhanced by Mitomycin-C Involves Induction of ATBF1 and Activation of p21 (Waf1/Cip1) Promoter

Microbiology and Immunology

Volumn 48, Issue 2, 2004, Pages 137-145

  Miura, Yutaka ^a   Kataoka, Hiromi ^a   Joh, Takashi ^a   Tada, Toyohiro ^b   Asai, Kiyofumi ^a   Nakanishi, Makoto ^a   Okada, Noriko ^a   Okada, Hidechika ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b NAGOYA CITY UNIVERSITY   (Japan)

Author keywords

Apoptosis; Myb; p21 (Waf1 Cip1); p53; Transcription factor

Indexed keywords

ALPHA FETOPROTEIN; AT MOTIF BINDING FACTOR 1; BINDING PROTEIN; GENE PRODUCT; MITOMYCIN C; PROTEIN P21; PROTEIN P53; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL CULTURE; CASE REPORT; CELL CYCLE; CONTROLLED STUDY; DRUG SENSITIVITY; GENE ACTIVATION; GENE INDUCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; KILLER CELL; LYMPHOKINE ACTIVATED KILLER CELL; MALE; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STOMACH CANCER;

EID: 1342325582     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2004.tb03491.x     Document Type: Article

References (29)

1. Amemiya, H., Kono, K., Mori, Y., Takahashi, A., Ichihara, F., Iizuka, H., Sekikawa, T., and Matsumoto, Y. 2000. High frequency of c-Met expression in gastric cancers producing alpha-fetoprotein. Oncology 59: 145-151.
2. Baldus, S.E., Goergen, D., Hanisch, F.G., and Dienes, H.P. 2001. Epitope-dependent differential immunoreactivities of anti-MUC1 monoclonal antibodies in human carcinomas. Int. J. Oncol. 18: 507-512.
3. Baldus, S.E., Zirbes, T.K., Engel, S., Hanisch, F.G., Monig, S.P., Lorenzen, J., Glossmann, J., Fromm, S., Thiele, J., Pichlmaier, H., and Dienes, H.P. 1998. Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas. Int. J. Cancer 79: 133-138.
4. Batra, S.K., and Hollingsworth, M.A. 1991. Expression of the human mucin gene, Muc 1, in normal tissues and metastatic pancreatic tumors. Int. J. Pancreatol. 10: 287-292.
5. Bourreille, J., Metayer, P., Sauger, F., Matray, F., and Fondimare, A. 1970. Existence of alpha feto protein during gastric-origin secondary cancer of the liver. Presse Med. 78: 1277-1278.
6. Chang, Y.C., Nagasue, N., Kohno, H., Taniura, H., Uchida, M., Yamanoi, A., Kimoto, T., and Nakamura, T. 1990. Clinicopathologic features and long-term results of alpha-fetoprotein-producing gastric cancer. Am. J. Gastroenterol. 85: 1480-1485.
7. Devine, P.L., Birrell, G.W., Whitehead, R.H., Harada, H., Xing, P.X., and McKenzie, I.F. 1992. Expression of MUC1 and MUC2 mucins by human tumor cell lines. Tumour Biol. 13: 268-277.
8. el-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W., and Vogelstein, B. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
9. Gunning, P., Leavitt, J., Muscat, G., Ng, S.Y., and Kedes, L. 1987. A human beta-actin expression vector system directs high-level accumulation of antisense transcripts. Proc. Natl. Acad. Sci. U.S.A. 84: 4831-4835.
10. Hess, R., Plaumann, B., Lutum, A.S., Haessler, C., Heinz, B., Fritsche, M., and Brandner, G. 1994. Nuclear accumulation of p53 in response to treatment with DNA-damaging agents. Toxicol. Lett. 72: 43-52.
11. Kaspar, P., Dvorakova, M., Kralova, J., Pajer, P., Kozmik, Z., and Dvorak, M. 1999. Myb-interacting protein, ATBF1, represses transcriptional activity of Myb oncoprotein. J. Biol. Chem. 274: 14422-14428.
12. Kataoka, H., Bonnefin, P., Vieyra, D., Feng, X., Hara, Y., Miura, Y., Joh, T., Nakabayashi, H., Vaziri, H., Harris, C.C., and Riabowol, K. 2003. ING1 represses transcription by direct DNA binding and through effects on p53. Cancer Res. 63: 5785-5792.
13. Kataoka, H., Miura, Y., Joh, T., Seno, K., Tada, T., Tamaoki, T., Nakabayashi, H., Kawaguchi, M., Asai, K., Kato, T., and Itoh, M. 2001. Alpha-fetoprotein producing gastric cancer lacks transcription factor ATBF1. Oncogene 20: 869-873.
14. Kawamura, A., Jr., Sekine, T., Sekiguchi, M., Yanoma, S., Kaneko, A., Haneda, T., Moriya, Y., Hayasaka, K., and Kakizoe, T. 2000. Six-year disease-free survival of a patient with metastatic eyelid squamous cell carcinoma and colon adenocarcinoma after repeated postoperative adoptive immunotherapy. Jpn. J. Clin. Oncol. 30: 267-271.
15. Konomi, Y., Sekine, T., Takayama, T., Fuji, M., and Tanaka, T. 1995. Cytotoxic activity of CD4+ T cells against autologous tumor cells. Jpn. J. Cancer Res. 86: 854-860.
16. Miura, Y., Tam, T., Ido, A., Morinaga, T., Miki, T., Hashimoto, T., and Tamaoki, T. 1995. Cloning and characterization of an ATBF1 isoform that expresses in a neuronal differentiation-dependent manner. J. Biol. Chem. 270: 26840-26848.
17. Mori, M., Ambe, K., Adachi, Y., Yakeishi, Y., Nakamura, K., Hachitanda, Y., Enjoji, M., and Sugimachi, K. 1988. Prognostic value of immunohistochemically identified CEA, SC, AFP, and S-100 protein-positive cells in gastric carcinoma. Cancer 62: 534-540.
18. Morinaga, T., Yasuda, H., Hashimoto, T., Higashio, K., and Tamaoki, T. 1991. A human α-fetoprotein enhancer-binding protein, ATBF1, contains four homeodomains and seventeen zinc fingers. Mol. Cell. Biol. 11: 6041-6049.
19. Nakashima, H., Sakada, T., Otsuka, M., Yoshikawa, Y., Ueo, H., Mori, M., and Akiyoshi, T. 1996. A case of alpha-fetoprotein-producing gastric cancer showing an exogastric growth pattern. J. Clin. Gastroenterol. 22: 150-153.
20. Nicoletti, I., Migliorati, G., Pagliacci, M.C., Grignani, F., and Riccardi, C. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139: 271-279.
21. Ochiai, T., Sato, H., Hayashi, R., Asano, T., and Yamamura, Y. 1983. Postoperative adjuvant immunotherapy of gastric cancer with BCG-cell wall skeleton. 3- to 6-year follow up of a randomized clinical trial. Cancer Immunol. Immunother. 14: 167-171.
22. Postigo, A.A., and Dean, D.C. 1999. Independent repressor domains in ZEB regulate muscle and T-cell differentiation. Mol. Cell. Biol. 19: 7961-7971.
23. Salomoni, P., Perrotti, D., Martinez, R., Franceschi, C., and Calabretta, B. 1997. Resistance to apoptosis in CTLL-2 cells constitutively expressing c-Myb is associated with induction of BCL-2 expression and Myb-dependent regulation of bcl-2 promoter activity. Proc. Natl. Acad. Sci. U.S.A. 94: 3296-3301.
24. Sekine, T., Shiraiwa, H., Yamazaki, T., Tobisu, K., and Kakizoe, T. 1993. A feasible method for expansion of peripheral blood lymphocytes by culture with immobilized anti-CD3 monoclonal antibody and interleukin-2 for use in adoptive immunotherapy of cancer patients. Biomed. Pharmacother. 47: 73-78.
25. Spicer, A.P., Parry, G., Patton, S., and Gendler, S.J. 1991. Molecular cloning and analysis of the mouse homologue of the tumor-associated mucin, MUC1, reveals conservation of potential O-glycosylation sites, transmembrane, and cytoplasmic domains and a loss of minisatellite-like polymorphism. J. Biol. Chem. 266: 15099-15109.
26. Takayama, T., Sekine, T., Makuuchi, M., Yamasaki, S., Kosuge, T., Yamamoto, J., Shimada, K., Sakamoto, M., Hirohashi, S., Ohashi, Y., and Kakizoe, T. 2000. Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet 356: 802-807.
27. Terashima, M., Ikeda, K., Maesawa, C., Kawamura, H., Niitsu, Y., Satoh, M., and Saito, K. 1991. Establishment of an alpha-fetoprotein-producing gastric cancer cell line in serum-free media. Jpn. J. Cancer Res. 82: 883-885.
28. Yamashita, T., Kasai, N., Miyoshi, I., Sasaki, N., Maki, K., Sakai, M., Nishi, S., and Namioka, S. 1993. High level expression of human alpha-fetoprotein in transgenic mice. Biochem. Biophys. Res. Commun. 191: 715-720.
29. Yasuda, H., Mizuno, A., Tamaoki, T., and Morinaga, T. 1994. ATBF1, a multiple-homeodomain zinc finger protein, selectively down-regulates AT-elements of the human α-fetoprotein gene. Mol. Cell. Biol. 14: 1395-1401.